A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis.

A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis.

OBJECTIVE: To determine the current disease-modifying anti-rheumatic drug (DMARD) preferences of UK consultant rheumatologists. METHODS: A questionnaire was sent in May 2002. We asked which DMARD(s) was most frequently preferred first and sought the most typical sequence of DMARDs, including DMARD c...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Jobanputra, P, Wilson, J, Douglas, K, Burls, A
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2004

Những quyển sách tương tự

A SURVEY OF DMARD PREFERENCES OF UK RHEUMATOLOGISTS
Bằng: Douglas, K, et al.
Được phát hành: (2003)

Doctors’ preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment
Bằng: T. Martijn Kuijper, et al.
Được phát hành: (2017-04-01)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
Bằng: Mysler E, et al.
Được phát hành: (2021-06-01)

When the first visit to the rheumatologist is established rheumatoid arthritis
Bằng: Taylor, P, et al.
Được phát hành: (2020)

Myocardial infarction in rheumatoid arthritis: The effects of DMARDs and prednisolone
Bằng: Edwards, C, et al.
Được phát hành: (2008)

Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
Bằng: Michael D George, et al.
Được phát hành: (2021-04-01)

Periodontal Health as Perceived by Rheumatologists and Rheumatoid Arthritis Patients
Bằng: Natasha Proud, et al.
Được phát hành: (2023-04-01)

DIAGNOSTIC MARKERS AND CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING DMARDS
Bằng: Maria Sergeevna Voronina, et al.
Được phát hành: (2012-10-01)

Biomarkers to Predict DMARDs Efficacy and Adverse Effect in Rheumatoid Arthritis
Bằng: Kai Wei, et al.
Được phát hành: (2022-03-01)

Clinical evaluation of DMARDs and NSAIDs in cases of Rheumatoid arthritis in Chhattisgarh
Bằng: Basant Kumar Maheshwari
Được phát hành: (2018-01-01)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
Bằng: Jobanputra, P, et al.
Được phát hành: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
Bằng: Jobanputra, P, et al.
Được phát hành: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
Bằng: P. Jobanputra, et al.
Được phát hành: (2002-01-01)

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
Bằng: Juthamas Prawjaeng, et al.
Được phát hành: (2023-05-01)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
Bằng: Barton, P, et al.
Được phát hành: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
Bằng: Barton, P, et al.
Được phát hành: (2004)

A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference
Bằng: Hamre HJ, et al.
Được phát hành: (2018-03-01)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis
Bằng: P Barton, et al.
Được phát hành: (2004-03-01)

Elderly-onset rheumatoid arthritis: an outlook from a practicing rheumatologist
Bằng: Ch. Baimukhamedov
Được phát hành: (2020-09-01)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction
Bằng: Barton, P, et al.
Được phát hành: (2004)

Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis
Bằng: Laurette van Boheemen, et al.
Được phát hành: (2020-09-01)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
Bằng: Clark, W, et al.
Được phát hành: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
Bằng: Clark, W, et al.
Được phát hành: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
Bằng: Clark, W, et al.
Được phát hành: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
Bằng: W Clark, et al.
Được phát hành: (2004-09-01)

Individual DMARDs have different effects on the likelihood of developing septic arthritis in adults with rheumatoid arthritis
Bằng: Edwards, C, et al.
Được phát hành: (2005)

COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs
Bằng: James Cheng-Chung Wei, et al.
Được phát hành: (2023-07-01)

Identification of biomarkers in patients with rheumatoid arthritis responsive to DMARDs but with progressive bone erosion
Bằng: Emiliano Marasco, et al.
Được phát hành: (2023-09-01)

Safety and efficacy of newer biologics DMARDs in the management of rheumatoid arthritis: A systematic review
Bằng: Basiru Ahmad Zago, et al.
Được phát hành: (2020-12-01)

Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
Bằng: Tillett, W, et al.
Được phát hành: (2020)

Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients
Bằng: Hazan Karadeniz, et al.
Được phát hành: (2022-04-01)

The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs
Bằng: Soo-Kyung Cho, et al.
Được phát hành: (2017-12-01)

Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis
Bằng: Esteban A. Gomez, et al.
Được phát hành: (2020-10-01)

Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study
Bằng: Seogsong Jeong, et al.
Được phát hành: (2022-07-01)

Challenges in implementing treat-to-target in rheumatoid arthritis: a perspective from Brazilian rheumatologists
Bằng: Adriana Maria Kakehasi, et al.
Được phát hành: (2024-08-01)

Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making
Bằng: Bolge SC, et al.
Được phát hành: (2016-06-01)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
Bằng: Ruiz Garcia, V, et al.
Được phát hành: (2014)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
Bằng: Ruiz Garcia, V, et al.
Được phát hành: (2011)

To flare or not to flare: patients’ and rheumatologists’ perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis
Bằng: Delphine Bertrand, et al.
Được phát hành: (2024-02-01)

The use of methotrexate in rheumatoid arthritis. Recommendations of the All-Russian public organization “Association of Rheumatologists of Russia”
Bằng: E. L. Nasonov, et al.
Được phát hành: (2023-08-01)